Skip to main content
. 2022 Dec 5;9:rbac098. doi: 10.1093/rb/rbac098

Figure 10.

Figure 10.

Biomaterials platform for regenerative medicine delivery. (A) The drug exhibit spatial distribution between different administrations for wound healing including miniaturized needle array (i), topical administration (ii) and liquid jet injector (iii). Adapted from Ref. [357] with permission of Wiley-VCH, © 2021. (B) Orally dosed milli-injector capsules enable nucleic acid delivery to swine stomachs. The right part shows hematoxylin and eosin-stained histology (upper) and immunohistochemistry histology (lower) stained against RNA encoding Cre recombinase enzyme. Scale bars indicate 200 mm. Adapted from Ref. [358] with permission of Elsevier, © 2022.